PCRX FY 2015 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$969M

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$249M+26.0% YoY

Gross Profit

$177M71.1% margin

Operating Income

$9M3.8% margin

Net Income

$2M0.7% margin

EPS (Diluted)

$0.04

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

-$12M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$390M

Total Liabilities

$171M

Stockholders' Equity

$218M

Cash & Equivalents

$159M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$249M	$198M	+26.0%
Gross Profit	$177M	$120M	+47.4%
Operating Income	$9M	-$5M	+283.1%
Net Income	$2M	-$14M	+113.5%